Language Models are Surprisingly Fragile to Drug Names in Biomedical Benchmarks
Harvard University and Maastricht University · Brigham and Women’s Hospital, Harvard University · Massachusetts Institute of Technology and Beth Israel Deaconess Medical Center · Harvard University · University of Virginia, Charlottesville
PDF 由论文原始站点提供,PaperCompass 不保存论文文件。DOI 10.18653/v1/2024.findings-emnlp.726 ↗
摘要
Medical knowledge is context-dependent and requires consistent reasoning across various natural language expressions of semantically equivalent phrases. This is particularly crucial for drug names, where patients often use brand names like Advil or Tylenol instead of their generic equivalents. To study this, we create a new robustness dataset, RABBITS, to evaluate performance differences on medical benchmarks after swapping brand and generic drug names using physician expert annotations.We assess both open-source and API-based LLMs on MedQA and MedMCQA, revealing a consistent performance drop ranging from 1-10%. Furthermore, we identify a potential source of this fragility as the contamination of test data in widely used pre-training datasets.